Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations.

por Richard A Hubner, Richard D Riley, Lucinda J Billingham, Sanjay Popat
Publicado 2011

Y disruption, autosomal hypomethylation and poor male lung cancer survival

por Saffron A. G. Willis-Owen, Clara Domingo-Sabugo, Elizabeth Starren, Liming Liang, Maxim B. Freidin, Madeleine Arseneault, Youming Zhang, Shir Kiong Lu, Sanjay Popat, Eric Lim, Andrew G. Nicholson, Yasser Riazalhosseini, Mark Lathrop, William O. C. Cookson, Miriam F. Moffatt
Publicado 2021

Early Response to Chemotherapy in Malignant Pleural Mesothelioma Evaluated Using Diffusion-Weighted Magnetic Resonance Imaging: Initial Observations

por Sebastian Curcean, M.B.B.S., Lin Cheng, PhD, Simona Picchia, MD, Nina Tunariu, MD, David Collins, PhD, Matthew Blackledge, PhD, Sanjay Popat, MD, Mary O’Brien, MD, Anna Minchom, MD, Martin O. Leach, PhD, Dow-Mu Koh, MD
Publicado 2021

Integrated genomics point to immune vulnerabilities in pleural mesothelioma

por Anca Nastase, Amit Mandal, Shir Kiong Lu, Hima Anbunathan, Deborah Morris-Rosendahl, Yu Zhi Zhang, Xiao-Ming Sun, Spyridon Gennatas, Robert C. Rintoul, Matthew Edwards, Alex Bowman, Tatyana Chernova, Tim Benepal, Eric Lim, Anthony Newman Taylor, Andrew G. Nicholson, Sanjay Popat, Anne E. Willis, Marion MacFarlane, Mark Lathrop, Anne M. Bowcock, Miriam F. Moffatt, William O. C. M. Cookson
Publicado 2021